KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Merck (MRK) Liabilities from Discontinued Operations (2020)

Merck has reported Liabilities from Discontinued Operations over the past 2 years, most recently at 1086000000.0 for Q4 2020.

Quarterly Liabilities from Discontinued Operations changed N/A to 1086000000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was 1086000000.0 through Dec 2020, changed N/A year-over-year, with the annual reading at 1086000000.0 for FY2020, N/A changed from the prior year.
Liabilities from Discontinued Operations was 1086000000.0 for Q4 2020 at Merck, up from 810000000.0 in the prior quarter.
Over five years, Liabilities from Discontinued Operations peaked at 1086000000.0 in Q4 2020 and troughed at 1086000000.0 in Q4 2020.